Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × liposomal doxorubicin × Clear all

NCT03387917 2024-12-02

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors